Gestational Diabetes Mellitus: The Dual Risk of Small and Large for Gestational Age: A Narrative Review
Medical Sciences · 19.08.2025 · 13 (3) · 144
DOI: 10.3390/medsci13030144 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 19.08.2025. Verfasst von Andreea Fotă und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, "Carol Davila" University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd., 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: Diabetes, Gestational, Fetal Development, Fetal Growth Retardation, Fetal Macrosomia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/Objectives: Gestational diabetes mellitus (GDM) complicates approximately 14% of pregnancies worldwide, its prevalence rising with increasing maternal age and obesity. While maternal hyperglycemia is traditionally associated with fetal overgrowth and large-for-gestational-age (LGA) neonates, emerging evidence indicates that GDM may also contribute to small-for-gestational-age (SGA) outcomes.
Methods
A comprehensive literature search was conducted using multiple databases, including PubMed, Web of Science, and ScienceDirect, to identify studies related to gestational diabetes mellitus, fetal growth outcomes such as small for gestational age and large for gestational age, and associated pathophysiological mechanisms.
Results
This narrative review explores the mechanisms by which GDM influences fetal growth, emphasizing the dual risk of excessive and restricted intrauterine growth. Fetal macrosomia typically results from chronic maternal hyperglycemia, leading to increased transplacental glucose delivery and fetal hyperinsulinemia. In contrast, SGA outcomes are a consequence of vascular and endothelial dysfunction, placental insufficiency, or excessively restrictive glycemic control that limit the availability of nutrients. Both extremes of fetal growth carry a myriad of significant perinatal and long-term metabolic risks.
Conclusions
Understanding the diverse pathways through which GDM affects fetal growth is essential for developing individualized clinical strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, "Carol Davila" University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd., 050474 Bucharest, Romania.
- Department of Obstetrics and Gynecology, Elias University Emergency Hospital, 17 Mărăști Blvd., 050474 Bucharest, Romania.
ORCID-Profile: Andreea Fotă, Aida Petca
Zitieren
APA
Fotă, A., & Petca, A. (2025). Gestational Diabetes Mellitus: The Dual Risk of Small and Large for Gestational Age: A Narrative Review. Medical Sciences, 13(3), 144. https://doi.org/10.3390/medsci13030144
Vancouver
Fotă A, Petca A. Gestational Diabetes Mellitus: The Dual Risk of Small and Large for Gestational Age: A Narrative Review. Medical Sciences. 2025;13(3):144. doi:10.3390/medsci13030144
BibTeX
@article{Fot2025,
author = {Fotă, Andreea and Petca, Aida},
title = {Gestational Diabetes Mellitus: The Dual Risk of Small and Large for Gestational Age: A Narrative Review},
journal = {Medical Sciences},
year = {2025},
volume = {13},
number = {3},
pages = {144},
doi = {10.3390/medsci13030144}
}
EUVIMED